Interpretation of Evidence-based Expert Consensus on the Clinical Management of Safety of Bruton′s Tyrosine Kinase Inhibitors (2024)

Jiang Dan, Song Zaiwei, Gao Yuan, Zhou Daobin, Li Yue, Zhang Lingli, Miao Liyan, Shao Qun, Ma Jun, Zhu Jun, Jing Hongmei, Zhao Rongsheng

PDF(3472 KB)
PDF(3472 KB)
Adverse Drug Reactions Journal ›› 2025, Vol. 27 ›› Issue (7) : 385-396. DOI: 10.3760/cma.j.cn114015-20241019-00100

Interpretation of Evidence-based Expert Consensus on the Clinical Management of Safety of Bruton′s Tyrosine Kinase Inhibitors (2024)

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 27(7): 385-396 https://doi.org/10.3760/cma.j.cn114015-20241019-00100

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(3472 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉